Global Radiopharmaceuticals in Nuclear Medical Market Insights, Forecast to 2025
- QYR2768131
- 124 Pages
- September 2018
- Medical Devices
This research report categorizes the global Radiopharmaceuticals in Nuclear Medical market by top players/brands, region, type and end user. This report also studies the global Radiopharmaceuticals in Nuclear Medical market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The global Radiopharmaceuticals in Nuclear Medical market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Radiopharmaceuticals in Nuclear Medical market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bracco Imaging
Cambridge Isotope Laboratories
Cardinal Health
Covidien
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries
Market size by Product
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Market size by End User
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Industrial
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Radiopharmaceuticals in Nuclear Medical market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Radiopharmaceuticals in Nuclear Medical market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Radiopharmaceuticals in Nuclear Medical companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Radiopharmaceuticals in Nuclear Medical submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Radiopharmaceuticals in Nuclear Medical are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Radiopharmaceuticals in Nuclear Medical market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Radiopharmaceuticals in Nuclear Medical Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Product
1.4.2 Diagnostic Radiopharmaceuticals
1.4.3 Therapy Radiopharmaceuticals
1.4.4 Enriched Stable Isotopes
1.5 Market by End User
1.5.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by End User
1.5.2 Diagnostic Application
1.5.3 Therapeutic Application
1.5.4 Research
1.5.5 Pharmaceutical
1.5.6 Industrial
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size
2.1.1 Global Radiopharmaceuticals in Nuclear Medical Revenue 2013-2025
2.1.2 Global Radiopharmaceuticals in Nuclear Medical Sales 2013-2025
2.2 Radiopharmaceuticals in Nuclear Medical Growth Rate by Regions
2.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Regions
2.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Radiopharmaceuticals in Nuclear Medical Sales by Manufacturers
3.1.1 Radiopharmaceuticals in Nuclear Medical Sales by Manufacturers
3.1.2 Radiopharmaceuticals in Nuclear Medical Sales Market Share by Manufacturers
3.1.3 Global Radiopharmaceuticals in Nuclear Medical Market Concentration Ratio (CR5 and HHI)
3.2 Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers
3.2.1 Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers (2013-2018)
3.2.2 Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2013-2018)
3.3 Radiopharmaceuticals in Nuclear Medical Price by Manufacturers
3.4 Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution, Product Types
3.4.1 Radiopharmaceuticals in Nuclear Medical Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medical Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Product
4.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Product
4.3 Radiopharmaceuticals in Nuclear Medical Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Radiopharmaceuticals in Nuclear Medical Breakdown Data by End User
6 North America
6.1 North America Radiopharmaceuticals in Nuclear Medical by Countries
6.1.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Countries
6.1.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Radiopharmaceuticals in Nuclear Medical by Product
6.3 North America Radiopharmaceuticals in Nuclear Medical by End User
7 Europe
7.1 Europe Radiopharmaceuticals in Nuclear Medical by Countries
7.1.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Countries
7.1.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Radiopharmaceuticals in Nuclear Medical by Product
7.3 Europe Radiopharmaceuticals in Nuclear Medical by End User
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical by Countries
8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Countries
8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical by Product
8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medical by End User
9 Central & South America
9.1 Central & South America Radiopharmaceuticals in Nuclear Medical by Countries
9.1.1 Central & South America Radiopharmaceuticals in Nuclear Medical Sales by Countries
9.1.2 Central & South America Radiopharmaceuticals in Nuclear Medical Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Radiopharmaceuticals in Nuclear Medical by Product
9.3 Central & South America Radiopharmaceuticals in Nuclear Medical by End User
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical by Countries
10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Countries
10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical by Product
10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medical by End User
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Details
11.1.2 Company Business Overview
11.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
11.1.5 Bracco Imaging Recent Development
11.2 Cambridge Isotope Laboratories
11.2.1 Cambridge Isotope Laboratories Company Details
11.2.2 Company Business Overview
11.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Products Offered
11.2.5 Cambridge Isotope Laboratories Recent Development
11.3 Cardinal Health
11.3.1 Cardinal Health Company Details
11.3.2 Company Business Overview
11.3.Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Products Offered
11.3.5 Cardinal Health Recent Development
11.4 Covidien
11.4.1 Covidien Company Details
11.4.2 Company Business Overview
11.4.3 Covidien Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Covidien Radiopharmaceuticals in Nuclear Medical Products Offered
11.4.5 Covidien Recent Development
11.5 Eczacibasi-Monrol
11.5.1 Eczacibasi-Monrol Company Details
11.5.2 Company Business Overview
11.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Products Offered
11.5.5 Eczacibasi-Monrol Recent Development
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Company Details
11.6.2 Company Business Overview
11.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
11.6.5 Fujifilm Holdings Corporation Recent Development
11.7 GE Healthcare (Subsidiary Of General Electric Company)
11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Details
11.7.2 Company Business Overview
11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Products Offered
11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
11.8 IBA Group
11.8.1 IBA Group Company Details
11.8.2 Company Business Overview
11.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Products Offered
11.8.5 IBA Group Recent Development
11.9 Lantheus Medical Imaging
11.9.1 Lantheus Medical Imaging Company Details
11.9.2 Company Business Overview
11.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
11.9.5 Lantheus Medical Imaging Recent Development
11.10 Nordion
11.10.1 Nordion Company Details
11.10.2 Company Business Overview
11.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2013-2018)
11.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Products Offered
11.10.5 Nordion Recent Development
11.11 Ntp Radioisotopes
11.12 Siemens Healthcare
11.13 Taiyo Nippon Sanso Corporation
11.14 Urenco Limited
11.15 Rotem Industries
12 Future Forecast
12.1 Radiopharmaceuticals in Nuclear Medical Market Forecast by Regions
12.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Regions 2018-2025
12.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Regions 2018-2025
12.2 Radiopharmaceuticals in Nuclear Medical Market Forecast by Product
12.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Product 2018-2025
12.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Product 2018-2025
12.3 Radiopharmaceuticals in Nuclear Medical Market Forecast by End User
12.4 North America Radiopharmaceuticals in Nuclear Medical Forecast
12.5 Europe Radiopharmaceuticals in Nuclear Medical Forecast
12.6 Asia Pacific Radiopharmaceuticals in Nuclear Medical Forecast
12.7 Central & South America Radiopharmaceuticals in Nuclear Medical Forecast
12.8 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Radiopharmaceuticals in Nuclear Medical Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Radiopharmaceuticals in Nuclear Medical Product Picture
Table Radiopharmaceuticals in Nuclear Medical Market Segments
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medical Covered
Table Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product 2013-2025
Figure Diagnostic Radiopharmaceuticals Product Picture
Table Major Manufacturers of Diagnostic Radiopharmaceuticals
Figure Therapy Radiopharmaceuticals Product Picture
Table Major Manufacturers of Therapy Radiopharmaceuticals
Figure Enriched Stable Isotopes Product Picture
Table Major Manufacturers of Enriched Stable Isotopes
Table Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Diagnostic Application
Figure Therapeutic Application
Figure Research
Figure Pharmaceutical
Figure Industrial
Figure Radiopharmaceuticals in Nuclear Medical Report Years Considered
Figure Global Radiopharmaceuticals in Nuclear Medical Market Size 2013-2025 (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales 2013-2025 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Sales by Regions 2013-2018 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Regions 2013-2018
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Regions 2013-2018
Figure 2017 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Regions
Table Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions 2013-2018 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions 2013-2018
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions 2013-2018
Figure 2017 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions
Table Global Radiopharmaceuticals in Nuclear Medical Sales by Manufacturers (2013-2018) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Share by Manufacturers (2013-2018)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers (2013-2018) (Million USD)
Table Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2013-2018)
Figure Radiopharmaceuticals in Nuclear Medical Value Share by Manufacturers in 2017
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medical Price (2013-2018) (USD/Unit)
Table Radiopharmaceuticals in Nuclear Medical Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
Table Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medical Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Radiopharmaceuticals in Nuclear Medical Sales by Product (2013-2018) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Share by Product (2013-2018)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2013-2018)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product in 2017
Table Global Radiopharmaceuticals in Nuclear Medical Revenue by Product (2013-2018) (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Product (2013-2018)
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Product (2013-2018)
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Product in 2017
Table Radiopharmaceuticals in Nuclear Medical Price by Product 2013-2018 (USD/Unit)
Table Global Radiopharmaceuticals in Nuclear Medical Sales by End User (2013-2018) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Share by End User (2013-2018)
Figure Global Sales Radiopharmaceuticals in Nuclear Medical Market Share by End User (2013-2018)
Figure Global Sales Radiopharmaceuticals in Nuclear Medical Market Share by End User in 2017
Figure North America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2013-2018 (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2013-2018 (Million US$)
Table North America Radiopharmaceuticals in Nuclear Medical Sales by Countries (2013-2018) (K Units)
Table North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2013-2018)
Figure 2017 North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table North America Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2013-2018) (Million US$)
Table North America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure United States Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure United States Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Canada Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Table North America Radiopharmaceuticals in Nuclear Medical Sales by Product (2013-2018) (K Units)
Table North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2013-2018)
Figure 2017 North America Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table North America Radiopharmaceuticals in Nuclear Medical Sales by End User (2013-2018) (K Units)
Table North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2013-2018)
Figure 2017 North America Radiopharmaceuticals in Nuclear Medical Market Share by End User
Figure Europe Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2013-2018 (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales by Countries (2013-2018) (K Units)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table Europe Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2013-2018) (Million US$)
Table Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure Germany Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Germany Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure France Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure France Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure UK Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Italy Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Russia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales by Product (2013-2018) (K Units)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2013-2018)
Figure 2017 Europe Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table Europe Radiopharmaceuticals in Nuclear Medical Sales by End User (2013-2018) (K Units)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2013-2018)
Figure 2017 Europe Radiopharmaceuticals in Nuclear Medical Market Share by End User
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure China Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure China Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Korea Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure India Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure India Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Australia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Product (2013-2018) (K Units)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by End User (2013-2018) (K Units)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Share by End User
Figure Central & South America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales by Countries (2013-2018) (K Units)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table Central & South America Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure Brazil Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales by Product (2013-2018) (K Units)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales by End User (2013-2018) (K Units)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Radiopharmaceuticals in Nuclear Medical Market Share by End User
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure GCC Countries Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Share by End User
Table Bracco Imaging Company Details
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bracco Imaging Recent Development
Table Cambridge Isotope Laboratories Company Details
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Cambridge Isotope Laboratories Recent Development
Table Cardinal Health Company Details
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Cardinal Health Recent Development
Table Covidien Company Details
Table Covidien Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Covidien Recent Development
Table Eczacibasi-Monrol Company Details
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Eczacibasi-Monrol Recent Development
Table Fujifilm Holdings Corporation Company Details
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Fujifilm Holdings Corporation Recent Development
Table GE Healthcare (Subsidiary Of General Electric Company) Company Details
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table IBA Group Company Details
Table IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table IBA Group Recent Development
Table Lantheus Medical Imaging Company Details
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Lantheus Medical Imaging Recent Development
Table Nordion Company Details
Table Nordion Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Nordion Recent Development
Table Ntp Radioisotopes Company Details
Table Siemens Healthcare Company Details
Table Taiyo Nippon Sanso Corporation Company Details
Table Urenco Limited Company Details
Table Rotem Industries Company Details
Table Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Regions 2018-2025 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Regions 2018-2025
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Regions 2018-2025
Table Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Product 2018-2025 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Product 2018-2025
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Product 2018-2025
Table Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by End User 2018-2025 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by End User 2018-2025
Figure North America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Radiopharmaceuticals in Nuclear Medical Value Chain
Table Radiopharmaceuticals in Nuclear Medical Customers List
Table Radiopharmaceuticals in Nuclear Medical Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
